These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1489903)

  • 21. Congenital thrombophilia among patients with venous thromboembolism.
    Melissari E; Monte G; Lindo VS; Pemberton KD; Wilson NV; Edmondson R; Das S; Kakkar VV
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):749-58. PubMed ID: 1489896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state.
    Patrassi GM; Sartori MT; Viero ML; Scarano L; Boscaro M; Girolami A
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):789-93. PubMed ID: 1489900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fibrinolysis studied by an in vitro clot lysis test in polycythemia vera].
    Pósán E; Ujj G; Kiss A; Telek B; Rák K; Udvardy M
    Orv Hetil; 1996 Jan; 137(2):71-4. PubMed ID: 8721871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet adhesiveness in polycythaemai rubra vera.
    Shield LK; Pearn JH
    Med J Aust; 1969 Apr; 1(14):711-5. PubMed ID: 5771314
    [No Abstract]   [Full Text] [Related]  

  • 27. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.
    Nilsson IM; Ljungnér H; Tengborn L
    Br Med J (Clin Res Ed); 1985 May; 290(6480):1453-6. PubMed ID: 3922531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples.
    Lewis MR; Callas PW; Jenny NS; Tracy RP
    Thromb Haemost; 2001 Dec; 86(6):1495-500. PubMed ID: 11776319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation and fibrinolytic systems in type I diabetes: effects of venous occlusion and insulin-induced hypoglycaemia.
    Wieczorek I; Pell AC; McIver B; MacGregor IR; Ludlam CA; Frier BM
    Clin Sci (Lond); 1993 Jan; 84(1):79-86. PubMed ID: 8382139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinolytic activity of endothelial cells from different venous beds.
    Kumar NG; Clark A; Roztocil E; Caliste X; Gillespie DL; Cullen JP
    J Surg Res; 2015 Mar; 194(1):297-303. PubMed ID: 25481530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and prognostic values of plasma levels of fibrinolytic markers in gastric cancer.
    Ho CH; Chao Y; Lee SD; Chau WK; Wu CW; Liu SM
    Thromb Res; 1998 Jul; 91(1):23-7. PubMed ID: 9700849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia.
    Barton MH; Morris DD; Norton N; Prasse KW
    J Vet Intern Med; 1998; 12(1):26-35. PubMed ID: 9503357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
    Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive.
    Cachrimanidou AC; Hellberg D; Nilsson S; von Schoulz B; Crona N; Siegbahn A
    Contraception; 1994 Aug; 50(2):153-65. PubMed ID: 7956214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip.
    Van Veldhuizen PJ; Neff J; Murphey MD; Bodensteiner D; Skikne BS
    Am J Hematol; 1993 Dec; 44(4):243-8. PubMed ID: 8237994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinolytic system in adolescents: response to venous occlusion stress tests.
    Monagle P; Chan AK; Albisetti M; Vegh P; Andrew M; Mitchell L
    Pediatr Res; 2003 Feb; 53(2):333-7. PubMed ID: 12538795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
    Gris JC; Neveu S; Mares P; Biron C; Hedon B; Schved JF
    J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.